Knoll Capital Management, LLC

Overview

• HeadquartersFL¹

See how the biggest companies compare on our leaderboards

Corporate structure

Knoll Capital Management, LLC sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies). Each entity in the chart links to its source.

Filings

23 filings to the SEC since October 2021: 23 other. The latest 20:

1. Sep 10, 202613F-HR/A EDGAR
2. Aug 31, 2026N-PX EDGAR
3. Aug 14, 202613F-HR EDGAR
4. May 15, 202613F-HR EDGAR
5. Feb 17, 202613F-HR EDGAR
6. Nov 14, 202513F-HR EDGAR
7. Aug 14, 202513F-HR EDGAR
8. May 15, 202513F-HR EDGAR
9. Feb 18, 202513F-HR EDGAR
10. Nov 14, 202413F-HR EDGAR
11. Sep 3, 2024N-PX EDGAR
12. Aug 14, 202413F-HR EDGAR
13. May 15, 202413F-HR EDGAR
14. Feb 14, 202413F-HR EDGAR
15. Nov 14, 202313F-HR EDGAR
16. Aug 15, 202313F-HR EDGAR
17. May 15, 202313F-HR EDGAR
18. Feb 14, 202313F-HR EDGAR
19. Nov 14, 202213F-HR EDGAR
20. Aug 15, 202213F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Knoll Capital Management, LLC has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).

• Elicio Therapeutics, Inc.SCHEDULE 13G/A Feb 5, 2025 to Jul 8, 2026²
• Entera Bio Ltd.SC 13G/A Jan 16, 2024 to Nov 20, 2024³
• Aldeyra Therapeutics, Inc.SC 13G Oct 4, 2023⁴
• HOOKIPA Pharma Inc.SC 13G Jun 20, 2023⁵
• Applied Therapeutics, Inc.SC 13G Jan 23, 2023⁶